Dara Azar

Stock Analyst at Stifel

(2.71)

# 0

Out of 0 analysts

2

Total ratings

100%

Success rate

63.26%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dara Azar

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SMMT Summit Therapeutics	Initiates: Buy	$45	$22.12	+103.44%	1	Apr 8, 2026
	INBX Inhibrx Biosciences	Initiates: Buy	$150	$131.45	+14.11%	1	Apr 8, 2026

Summit Therapeutics

Apr 8, 2026

Initiates: Buy

Price Target: $45

Current: $22.12

Upside: +103.44%

Inhibrx Biosciences

Apr 8, 2026

Initiates: Buy

Price Target: $150

Current: $131.45

Upside: +14.11%